Re-purposing of approved drugs from DrugBank database for possible treatment for COVID-19 by targeting SARS-CoV-2 main protease
- Funded by SERB India
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
SERB IndiaPrincipal Investigator
N/A
Research Location
IndiaLead Research Institution
Indian Institute of Technology, BHU, Uttar PradeshResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Drug repurposing against key COVID-19 targets